Ghosh D, Roy A K, Murmu N, Mandal S, Roy A
Department of Pathology and Cancer Screening, Chittaranjan National Cancer Institute, Kolkata, India. Email:
Asian Pac J Cancer Prev. 2019 Feb 26;20(2):549-555. doi: 10.31557/APJCP.2019.20.2.549.
Objective: To identify high risk HPV associations by evaluating linked p16 overexpression and also the expression of p53 and RARβ together with histopathology for risk categorization of cervical pre-neoplastic lesions. Materials and Methods: Immunohistochemical staining was performed on 100 cases of cervical pre- neoplastic lesions for expression of biomarkers like p16, p53 and RARβ for comparison with haematoxylin/eosin (HE) findings. All the experimentally generated data were statistically analyzed. Results: In this study 70% cases showed overexpression of p16INK4A increasing progressively from CIN I to CIN II but reduced in CIN III (p <0.01). p53 oncoprotein expression was seen in 51% cases, again with increments from CIN I to CIN II with slight reduction in CIN III (p<0.01). Some 24% cases showed negative immunoreactivity for the putative tumor suppressor gene RARβ (p>0.05). Conclusion: Our study provides support for the idea that p16 can be used to identify associations with HPV , as well as having potential along with p53 and RARβ for categorizing cervical pre-neoplastic cases having a higher risk of neoplastic conversion. Thus it may be concluded that accurate risk categorization can be achieved with the help of genetic markers as well as histopathology.
通过评估相关的p16过表达以及p53和RARβ的表达,并结合组织病理学,来确定高危型人乳头瘤病毒(HPV)的关联,从而对宫颈肿瘤前病变进行风险分类。材料与方法:对100例宫颈肿瘤前病变进行免疫组织化学染色以检测生物标志物如p16、p53和RARβ的表达,并与苏木精/伊红(HE)染色结果进行比较。对所有实验产生的数据进行统计学分析。结果:在本研究中,70%的病例显示p16INK4A过表达,从CIN I到CIN II逐渐增加,但在CIN III中降低(p<0.01)。51%的病例可见p53癌蛋白表达,同样从CIN I到CIN II增加,在CIN III中略有降低(p<0.01)。约24%的病例对假定的肿瘤抑制基因RARβ呈阴性免疫反应(p>0.05)。结论:我们的研究支持以下观点,即p16可用于识别与HPV的关联,并且与p53和RARβ一起,对于对具有较高肿瘤转化风险的宫颈肿瘤前病例进行分类具有潜力。因此可以得出结论,借助基因标志物以及组织病理学可以实现准确的风险分类。